Trial Profile
A Phase 4, multicentre, observational cohort study of Use of Belimumab in Clinical Practice SEttings (OBSErve)
Status:
Recruiting
Phase of Trial:
Phase IV
Latest Information Update: 06 Sep 2023
Price :
$35
*
At a glance
- Drugs Belimumab (Primary)
- Indications Systemic lupus erythematosus
- Focus Therapeutic Use
- Acronyms OBSErve
- Sponsors GlaxoSmithKline; GSK
- 01 Feb 2017 New trial record